KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study

Mutations in KRAS, NRAS, and BRAF (RAS/BRAF) genes are the main predictive biomarkers for the response to anti-EGFR monoclonal antibodies (MAbs) targeted therapy in metastatic colorectal cancer (mCRC). This retrospective study aimed to report the mutational status prevalence of these genes, explore...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez-Ibarra, Hector Eduardo, Jiang, Xianli, Gallegos-Gonzalez, Elena Yareli, Cavazos-González, Adriana Carolina, Chen, Yenho, Morcos, Faruck, Barrera-Saldaña, Hugo Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337295/
https://www.ncbi.nlm.nih.gov/pubmed/32628708
http://dx.doi.org/10.1371/journal.pone.0235490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337295/
https://www.ncbi.nlm.nih.gov/pubmed/32628708
http://dx.doi.org/10.1371/journal.pone.0235490

Ejemplares similares